Related Experiment Video
Updated: Apr 27, 2026

Rescue of Recombinant Newcastle Disease Virus from cDNA
Published on: October 11, 2013
ISG12a mediates cell response to Newcastle disease viral infection
Nianli Liu1, Ying Long2, Bin Liu2
1Department of Molecular Medicine, State Key Laboratory of Chemo/Biosensing and Chemometrics, Hunan University, Changsha 410082, China; Research Center of Cancer Prevention & Treatment, Translational Medicine Research Center of Liver Cancer, Hunan Provincial Tumor Hospital (Affiliated Tumor Hospital of Xiangya Medical School of Central South University), Changsha 410013, China.
Abstract:
Newcastle disease virus (NDV) oncolysis is believed to be facilitated by a defective Type I interferon (IFN) response. We compared hepatocellular carcinoma (HCC)-derived cell lines and found that TRAIL-resistant cells were more susceptible to NDV oncolysis than were TRAIL-sensitive cells. In examining the IFN response, we found that basal expression of the IFN-stimulated gene (ISG)-12a was low in TRAIL-resistant but high in TRAIL-sensitive cells, and ISG12a over-expression or silencing enhanced or reduced their TRAIL sensitivities, respectively. Moreover, ISG12a over-expression in TRAIL-resistant cells decreased NDV replication but surprisingly increased oncolysis while ISG12a silencing had the opposite effect on TRAIL-sensitive cells. Finally, RIG-I and Noxa appear to also contribute to NDV oncolysis. Together, these results suggest that high basal ISG12a may inhibit NDV replication and oncolysis, while low basal ISG12a may allow sufficient NDV replication for induction of ISG12a, and other factors required for NDV oncolysis, with implications for future therapeutics.
Insights
Newcastle disease virus (NDV) oncolysis in cancer cells depends on interferon responses. Low interferon-stimulated gene 12a (ISG-12a) levels promote NDV oncolysis, suggesting therapeutic potential.
Area of Science:
- Virology
- Immunology
- Oncology
Background:
- Newcastle disease virus (NDV) is a promising oncolytic virus, with its efficacy potentially linked to the host's Type I interferon (IFN) response.
- Hepatocellular carcinoma (HCC) is a major global health concern, and understanding viral oncolysis mechanisms in HCC is crucial for developing new therapies.
Purpose of the Study:
- To investigate the role of Type I interferon response, specifically interferon-stimulated gene 12a (ISG-12a), in Newcastle disease virus (NDV) oncolysis of hepatocellular carcinoma (HCC) cells.
- To compare the susceptibility of TRAIL-resistant and TRAIL-sensitive HCC cells to NDV oncolysis and elucidate the underlying IFN-related mechanisms.
Main Methods:
- Comparative analysis of TRAIL-resistant and TRAIL-sensitive HCC cell lines.
- Assessment of NDV replication and oncolysis.
- Investigation of basal and induced expression of ISG-12a.
- Manipulation of ISG-12a expression (over-expression and silencing).
- Evaluation of the roles of RIG-I and Noxa in NDV oncolysis.
Main Results:
- TRAIL-resistant HCC cells, with lower basal ISG-12a expression, were more susceptible to NDV oncolysis than TRAIL-sensitive cells.
- Over-expression of ISG-12a in TRAIL-resistant cells reduced NDV replication but enhanced oncolysis, while ISG-12a silencing in TRAIL-sensitive cells had opposite effects.
- RIG-I and Noxa were identified as contributing factors to NDV oncolysis.
Conclusions:
- Basal levels of ISG-12a significantly influence NDV oncolysis, with low levels promoting viral replication and subsequent oncolysis.
- ISG-12a modulation presents a potential therapeutic strategy to enhance NDV oncolysis in HCC.
- The interplay between IFN response, viral replication, and cell death pathways is critical for effective oncolytic virotherapy.
More Related Videos
Related Concept Videos
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Cell-mediated Immune Responses
Inhibitors of Viral Protein Synthesis

